Connect with us at BIO-Europe Spring 2021!
Sichuan Kelun-Biotech Pharmaceutical Co., Ltd. and UK company Ellipses Pharma Ltd. Announce a Licensing Agreement for Innovative Small Molecule Cancer Therapeutics
KLUS Pharma will attend BIO-Europe Spring Digital Event held on March 22-25, 2021.
KLUS Pharma will attend BIO Partnering at JPM Digital Event held on January 11-15, 2021.
The IND for KL-A289, an anti-LAG-3 monoclonal antibody, was recently approved by the NMPA in China.
We are looking for partnerships to develop and distribute ACV200-17, a peptide drug to prevent COVID-19, in affected countries.
KLUS Pharma will present an update for SKB264, a novel TROP2 ADC, at BIO Digital Event held on June 8-12, 2020.